The urokinase plasminogen activator receptor (uPAR),  which consists of 3 domains (domains I, II, and III), is an extracellular protein anchored to the plasma membrane via a glycosylphosphatidylinositol moiety located on domain III (4).
What does URK stand for?
URK stands for Urokinase
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Urban and Regional Information Systems Association
- Undergraduate Research, Innovation, Scholarship and Creativity
- University Research Initiative Support Program (est. 1994; US DoD)
- Undergraduate Research Implementation Team
- University of Rhode Island Transportation Center (Kingston, RI)
- Your Recommendation Is Requested
- Union for Reform Judaism
- Union Ridge Jacket
- Uraj (Russia)
- Universidad Rey Juan Carlos (Spanish, Madrid)
- Internet Shortcut (file name extension)
- Ubiquity Now, Revenues Later
- Underground Race League (video game)
- Unfinanced Requirements List
- Uniform Resource Locator (aka Universal Resource Locator)
- Unità di Ricerca Locali (Italian)
- Universal Republic of Love
- Universal Resource Locator (aka Uniform Resource Locator)
- Universal Ride Layout
- Universidad Rafael Landivar (Rafael Landivar University, Guatemala)
Samples in periodicals archive:
2,3 AnaSpec is pleased to introduce two plasminogen activator assay kits - the SensoLyteO AFC Urokinase (uPA) Assay Kit and the SensoLyteO AMC tPA Assay Kit.
``He has trouble seeing to one side and he walks with a cane, but he's a rancher, and he's back doing what ranchers do,'' eight months after the drug urokinase was administered to dissolve the clot and restore healthy blood flow to the brain, Clark said.
ViroGates A/S (Birkerod, Denmark) has patented a method of diagnosing and/or prognosticating HIV infection in a subject comprising the steps of: (a) performing in vitro a measurement of the level of a marker in the form of (i) urokinase plasminogen activator receptor (uPAR), (ii) soluble urokinase plasminogen activator receptor (suPAR), (iii) urokinase-type plasminogen activator (uPA), (iv) one or more degradation products of (i), (ii) or (iii), and/or (v) an mRNA for (i), (ii) or (iii), in a biological fluid sample from a subject, and (b) using the measurement value obtained to evaluate the state of the subject.